Home › Metastatic Cancer › California › Mountain View
Pag-aaral pangklinika para sa Metastatic Cancer sa Mountain View, CA
Isang pag-aaral para sa Metastatic Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Mountain View. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Nagre-recruitPhase 2
- Stanford Cancer Institute Palo Alto, Palo Alto · 5 mi ang layo
- VA Palo Alto Health Care System, Palo Alto · 5 mi ang layo
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
Nagre-recruitPhase 1/2
- Stanford, Palo Alto · 5 mi ang layo
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Nagre-recruitPhase 2/3
- Stanford Cancer Center, Palo Alto · 5 mi ang layo
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Nagre-recruitPhase 3
- Palo Alto Medical Foundation - Palo Alto Center, Palo Alto · 5 mi ang layo
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Nagre-recruitPhase 1/2
- Stanford Medicine, Palo Alto · 5 mi ang layo
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Nagre-recruitPhase 1
- Stanford Cancer Institute, Stanford · 5 mi ang layo
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Nagre-recruitPhase 1
- Stanford University Medical Center, Stanford · 5 mi ang layo
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Nagre-recruitPhase 3
- Stanford Women's Cancer Center, Palo Alto · 5 mi ang layo
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Nagre-recruitPhase 3
- Stanford Cancer Center, Palo Alto · 5 mi ang layo
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Nagre-recruitPhase 1/2
- Stanford Cancer Institute, Stanford · 5 mi ang layo
Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.
Nagre-recruitPhase 2
- Stanford University, Palo Alto · 5 mi ang layo
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
Nagre-recruitPhase 3
- Research Site, Palo Alto · 5 mi ang layo
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
Nagre-recruitPhase 1/2
- Stanford Cancer Institute (SCI), Stanford · 5 mi ang layo
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Nagre-recruitPhase 1
- Stanford Medicine Cancer Center, Stanford · 5 mi ang layo
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Stanford Cancer Institute, Stanford University, Palo Alto · 5 mi ang layo
Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases
Nagre-recruitPhase 3
- Stanford University School of Medicine, Palo Alto · 5 mi ang layo
A Study of LY4175408 in Participants With Advanced Cancer
Nagre-recruitPhase 1
- Stanford Medicine Cancer Center, Stanford · 5 mi ang layo
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Nagre-recruitPhase 1/2
- Stanford Cancer Institute, Stanford · 5 mi ang layo
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
Nagre-recruitPhase 2/3
- Stanford Health Care - Skin Cancer Program, Stanford · 5 mi ang layo
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Nagre-recruitPhase 2/3
- Stanford Cancer Institute, Palo Alto · 5 mi ang layo
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Nagre-recruitPhase 1
- Stanford Cancer Institute, Stanford · 5 mi ang layo
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Nagre-recruitPhase 1
- Stanford Cancer Institute, Stanford · 5 mi ang layo
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
Nagre-recruitObservasyonal na pag-aaral
- VA Palo Alto Healthcare System, Palo Alto · 5 mi ang layo
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Nagre-recruitPhase 1
- Stanford Cancer Institute, Palo Alto · 5 mi ang layo
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Stanford · 5 mi ang layo
Pag-aaral para sa Metastatic Cancer sa ibang lungsod
- Houston, TX104 pag-aaral
- New York City, NY93 pag-aaral
- Nashville, TN70 pag-aaral
- Boston, MA63 pag-aaral
- Los Angeles, CA57 pag-aaral
- St. Louis, MO54 pag-aaral
- Arlington, VA53 pag-aaral
- Philadelphia, PA46 pag-aaral
- Chicago, IL45 pag-aaral
- San Antonio, TX44 pag-aaral
- Washington, DC43 pag-aaral
- Dallas, TX42 pag-aaral
Iba pang pag-aaral sa Mountain View
- Kanser (lahat ng uri)40 pag-aaral
- Kanser sa Suso26 pag-aaral
- Non-Small Cell Lung Cancer21 pag-aaral
- Acute Myeloid Leukemia19 pag-aaral
- Kanser sa Ovary19 pag-aaral
- Autism Spectrum Disorder17 pag-aaral
- Kanser sa Baga17 pag-aaral
- Kanser sa Prostate15 pag-aaral
- Pagkabigo ng Puso15 pag-aaral
- Autism13 pag-aaral
- Acute Lymphoblastic Leukemia13 pag-aaral
- Colorectal Cancer13 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.